Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 10, 2015, Pages 1819-1826

  Gierth, M ^a   Mayr, R ^a   Aziz, A ^a   Krieger, S ^b   Wullich, B ^b   Pycha, A ^c   Lodde, M ^c   Salvadori, U ^c   Brundl J ^a   Fritsche, H M ^a   Hofstadter F ^a   Pawlik, M T ^d   Otto, W ^a   May, M ^e   Burger, M ^a   Denzinger, S ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

^d Department of Immunohaematology and Transfusion Medicine Central Hospital of Bolzano ^*  (Germany)

^e Urologische Klinik   (Germany)

Author keywords

Bladder cancer; Preoperative anemia; Prognosis; Radical cystectomy; Survival

Indexed keywords

HEMOGLOBIN;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGE; AGED; ANEMIA; ARTICLE; BLADDER CARCINOMA; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OPERATIVE BLOOD LOSS; PELVIS LYMPHADENECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; LYMPH NODE DISSECTION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS;

AGED; ANEMIA; BLOOD TRANSFUSION; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84939561879     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-1957-7     Document Type: Article

References (28)

1. Benoist S, Panis Y, Pannegein V, Alves A, Valleur P (2001) Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery 129:433–439
2. Beutler E, Waalen J (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107:1747–1750
3. Birgegard G, Aapro MS, Bokemeyer C, Dicato M, Drings P, Hornedo J et al (2005) Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 68(Suppl 1):3–11
4. Blanc B, Finch CA, Hallberg L et al (1968) Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405:5–37
5. Bruins HM, Arends T, Pelkman M, van der Heijden A, Witjes AJ (2013) The prognostic value of preoperative laboratory parameters in patients undergoing radical cystectomy for bladder cancer. J Urol 189:e584
6. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakoewicz PI et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241
7. Carson JL, Poses RM, Spence RK, Bonavita G (1988) Severity of anaemia and operative mortality and morbidity. Lancet 1:727–729
8. Chang SS, Smith JA, Wells N, Peterson M, Kovach B, Cookson MS (2001) Estimated blood loss and transfusion requirements of radical cystectomy. J Urol 166:2151–2154
9. Cook JD, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101:3359–3364
10. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC et al (2001) Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 71:769–776
11. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM (2002) Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102:237–244
12. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474
13. Fujisawa M, Gotoh A, Nakamura I, Hara IS, Okada H, Yamanaka N et al (2000) Long term assessment of serum vitamin B(12) concentrations in patients with various types of orthotopic intestinal neobladder. Urology 56:236–240
14. Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, et al. (2014) The effect of intra- and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder. World J Urol 32:1447–1453
15. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
16. Jazieh AR, Hussain M, Howington JA, Spencer HJ, Husain M, Grismer JT, Read RC (2000) Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 70:1168–1171
17. Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK (2011) Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 212:187–194
18. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF et al (2013) The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63:839–845
19. Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E et al (2012) Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int 110:E222–E227
20. Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000) Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev 26:303–311
21. Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE et al (2013) The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 31:871–877
22. Novotny V, Hakenberg OW, Wiessner D, Heberling U, Litz RJ, Oehlschlaeger S, Wirth MP (2007) Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 51:397–401 (discussion 401–402)
23. Rink M, Fejkovic H, Cha EK, Gupta A, Karakoewicz PI, Chun FK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854–855
24. Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA et al (2014) Impact of preoperative anemia on oncological outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 191:316–322
25. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB et al (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169:110–115 (discussion 115)
26. Steiner MS, Morton RA, Marshall FF (1993) Vitamin B12 deficiency in patients with ileocolic neobladders. J Urol 149:255–257
27. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ et al (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 59:1009–1018
28. Wigren T (1997) Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer. Radiother Oncol 44:9–15